CfDNA epigenetic profiling for tissue-of-origin mapping, accelerated aging, and cardiotoxicity biomarker discovery in cardio-oncology
Plasma cfDNA methylome profiling identifies a cardiac fibroblast-derived signal epigenetic changes associated with cardiotoxicity and cardiac dysfunction and support targeted cfDNA methylation as a promising non-invasive approach for monitoring and biomarker discovery in cardio-oncology and warrant validation in larger...